Catalyst Wire Dossier Catalyst Wire Dossier

Myrbetriq (mirabegron)

mirabegron · Astellas Pharma
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Myrbetriq (mirabegron), covering 2012-12-11 to 2024-07-12. Get the full timeline:

Most recent: Clinical Trial Update: Mirabegron and Physiological Function in Cold Environments [Phase 1, Phase 2]

See pricing